ARCHIVES

NCI “Can’t Justify Size Of Intramural Program”

This article is from The Cancer Letter archive.

Vol. 21 No. 19 | May 12, 1995

Download PDF Visit The Full Archive

Related Articles

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

RFA Available: Chemoprevention Trials

August 5, 1994

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985

Harold Amos Receives Drew Medical Prize

October 27, 1989

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008